- Last Close 1.62
- Sector Healthcare
- Industry Medical Devices
- Investment Style Small Value
- Day Range 1.62 – 1.81
- Year Range 0.81 – 2.40
- Market Cap 15.0833 Mil
- Volume / Avg 32,351.0 / 81,694.0
- Price / Sales 2.46
- Price / Book 2.56
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis NSPR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile NSPR
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.
Tel Aviv, 6744832, ISR
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
ShockWave Medical Inc
Bioventus Inc Class A
|+$0.18 (11.12%)||+$0.48 (1.93%)||−$1.71 (0.62%)||−$0.07 (2.41%)|
|15.08 Mil||892.97 Mil||10.05 Bil||177.46 Mil|
|Medical Devices||Medical Devices||Medical Devices||Medical Devices|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for InspireMD Inc Stock
No. NSPR does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
NSPR’s market cap is 15.08 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
NSPR’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
NSPR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare NSPR’s historical performance against its industry peers and the overall market.